What is Evommune 's diluted (in shares)?

Evommune (EVMN) reported diluted (in shares) of 19.6M in Q1 2026.

How has Evommune 's diluted (in shares) changed year-over-year?

Evommune 's diluted (in shares) increased by 183.3% year-over-year, from 6.9M to 19.6M.

What does diluted (in shares) mean?

Indicates the total number of common shares that would be outstanding if all dilutive instruments were converted into common stock. This metric is used to calculate diluted earnings per share and helps investors understand the potential for future equity dilution. It is a key indicator of the company's total potential ownership base.

Evommune EVMN Diluted (in shares)

Diluted (in shares) at other companies

Evommune EVMN

19.6M+183%

KEE

Keel Infrastructure Corp. Common StockKEEL

602.6M+20.5%

Ondas, Inc. ONDS

461.7K+340%

PopularBPOP

64.9M-6.4%

CHE

ChemedCHE

13.7M-7.3%

Quantum Computing Inc.QUBT

224M+46.4%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's diluted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's diluted (in shares)?: Evommune (EVMN) reported diluted (in shares) of 19.6M in Q1 2026.
How has Evommune 's diluted (in shares) changed year-over-year?: Evommune 's diluted (in shares) increased by 183.3% year-over-year, from 6.9M to 19.6M.
What does diluted (in shares) mean?: Indicates the total number of common shares that would be outstanding if all dilutive instruments were converted into common stock. This metric is used to calculate diluted earnings per share and helps investors understand the potential for future equity dilution. It is a key indicator of the company's total potential ownership base.